Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Vasculitis » Systemic Vasculitis » Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis » Churg-Strauss Syndrome
Diseases [C] » Hemic and Lymphatic Diseases [C15] » Lymphatic Diseases » Lymphoproliferative Disorders » Granuloma » Churg-Strauss Syndrome
Diseases [C] » Immune System Diseases [C20] » Autoimmune Diseases » Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis » Churg-Strauss Syndrome
Description
Widespread necrotizing angiitis with granulomas. Pulmonary involvement is frequent. Asthma or other respiratory infection may precede evidence of vasculitis. Eosinophilia and lung involvement differentiate this disease from POLYARTERITIS NODOSA. MeSH
Hierarchy View
Phase 3 Indicated Drugs (3)
Phase 2 Indicated Drugs (1)
Other Experimental Indicated Drugs (4)
Organization Involved with Phase 4 Indications (5)
Organization Involved with Phase 3 Indications (4)
Organization Involved with Phase 2 Indications (10)
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (2)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
